Статті в журналах з теми "Muramyl tripeptide"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Muramyl tripeptide".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Moyer, Paula. "Muramyl tripeptide for treatment of osteosarcoma." Lancet Oncology 9, no. 3 (March 2008): 207. http://dx.doi.org/10.1016/s1470-2045(08)70057-3.
Повний текст джерелаSilverman, D. H., J. M. Krueger, and M. L. Karnovsky. "Specific binding sites for muramyl peptides on murine macrophages." Journal of Immunology 136, no. 6 (March 15, 1986): 2195–201. http://dx.doi.org/10.4049/jimmunol.136.6.2195.
Повний текст джерелаMeyers, Paul A. "Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma." Expert Review of Anticancer Therapy 9, no. 8 (August 2009): 1035–49. http://dx.doi.org/10.1586/era.09.69.
Повний текст джерелаGoldbach, P., S. Dumont, R. Kessler, P. Poindron, and A. Stamm. "In situ activation of mouse alveolar macrophages by aerosolized liposomal IFN-gamma and muramyl tripeptide." American Journal of Physiology-Lung Cellular and Molecular Physiology 270, no. 3 (March 1, 1996): L429—L434. http://dx.doi.org/10.1152/ajplung.1996.270.3.l429.
Повний текст джерелаKleinerman, Eugenie S. "Biologic Therapy for Osteosarcoma Using Liposome-Encapsulated Muramyl Tripeptide." Hematology/Oncology Clinics of North America 9, no. 4 (August 1995): 927–38. http://dx.doi.org/10.1016/s0889-8588(18)30079-0.
Повний текст джерелаKleinerman, Eugenie S., Paul A. Meyers, Austin K. Raymond, Jacalyn B. Gano, Shu-Fang Jia, and Norman Jaffe. "Combination Therapy with Ifosfamide and Liposome-Encapsulated Muramyl Tripeptide." Journal of Immunotherapy 17, no. 2 (April 1995): 181–93. http://dx.doi.org/10.1097/00002371-199504000-00007.
Повний текст джерелаAnderson, Peter. "Liposomal muramyl tripeptide phosphatidyl ethanolamine: ifosfamide-containing chemotherapy in osteosarcoma." Future Oncology 2, no. 3 (June 2006): 333–43. http://dx.doi.org/10.2217/14796694.2.3.333.
Повний текст джерелаMurray, J. L., E. S. Kleinerman, J. E. Cunningham, J. R. Tatom, K. Andrejcio, J. Lepe-Zuniga, L. M. Lamki, M. G. Rosenblum, H. Frost, and J. U. Gutterman. "Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients." Journal of Clinical Oncology 7, no. 12 (December 1989): 1915–25. http://dx.doi.org/10.1200/jco.1989.7.12.1915.
Повний текст джерелаGay, B., H. Towbin, C. Schnell, K. Einsle, P. Graf, and D. Gygax. "Direct chemiluminescence immunoassay (CLIA) for muramyl tripeptide phosphatidyl-ethanolamine in plasma." Journal of Bioluminescence and Chemiluminescence 6, no. 2 (April 1991): 73–80. http://dx.doi.org/10.1002/bio.1170060204.
Повний текст джерелаKarpoff, Howard M., William Jarnagin, Keith Delman, and Yuman Fong. "Regional muramyl tripeptide phosphatidylethanolamine administration enhances hepatic immune function and tumor surveillance." Surgery 128, no. 2 (August 2000): 213–18. http://dx.doi.org/10.1067/msy.2000.107420.
Повний текст джерелаFedoročko, P. "Liposomal Muramyl Tripeptide Phosphatidylethanolamine (MTP-PE) Promotes Haemopoietic Recovery in Irradiated Mouse." International Journal of Radiation Biology 65, no. 4 (January 1994): 465–75. http://dx.doi.org/10.1080/09553009414550541.
Повний текст джерелаFogler, W. E., R. Wade, D. E. Brundish, and I. J. Fidler. "Distribution and fate of free and liposome-encapsulated [3H]nor-muramyl dipeptide and [3H]muramyl tripeptide phosphatidylethanolamine in mice." Journal of Immunology 135, no. 2 (August 1, 1985): 1372–77. http://dx.doi.org/10.4049/jimmunol.135.2.1372.
Повний текст джерелаSobral, R. G., A. M. Ludovice, H. de Lencastre, and A. Tomasz. "Role of murF in Cell Wall Biosynthesis: Isolation and Characterization of a murF Conditional Mutant of Staphylococcus aureus." Journal of Bacteriology 188, no. 7 (April 1, 2006): 2543–53. http://dx.doi.org/10.1128/jb.188.7.2543-2553.2006.
Повний текст джерелаFogler, William E., and Isaiah J. Fidler. "Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes." International Journal of Immunopharmacology 9, no. 2 (January 1987): 141–50. http://dx.doi.org/10.1016/0192-0561(87)90088-9.
Повний текст джерелаNardin, A., M. Lefebvre, K. Labroquere, O. Faure, and J. Abastado. "Liposomal Muramyl Tripeptide Phosphatidylethanolamine: Targeting and Activating Macrophages for Adjuvant Treatment of Osteosarcoma." Current Cancer Drug Targets 6, no. 2 (March 1, 2006): 123–33. http://dx.doi.org/10.2174/156800906776056473.
Повний текст джерелаKleinerman, Eugenie S., Jacalyn B. Gano, Dennis A. Johnston, Robert S. Benjamin, and Norman Jaffe. "Efficacy of Liposomal Muramyl Tripeptide (CGP 19835A) in the Treatment of Relapsed Osteosarcoma." American Journal of Clinical Oncology 18, no. 2 (April 1995): 93–99. http://dx.doi.org/10.1097/00000421-199504000-00001.
Повний текст джерелаMacEwen, E. G., I. D. Kurzman, R. C. Rosenthal, B. W. Smith, P. A. Manley, J. K. Roush, and P. E. Howard. "Therapy for Osteosarcoma in Dogs With Intravenous Injection of Liposome-Encapsulated Muramyl Tripeptide." JNCI Journal of the National Cancer Institute 81, no. 12 (June 21, 1989): 935–38. http://dx.doi.org/10.1093/jnci/81.12.935.
Повний текст джерелаJarowenko, Daleela Getsiv, Scott C. Sigler, and Neal R. Pellis. "Muramyl tripeptide: An effective immunotherapy in the surgical setting for pediatric abdominal neoplasms." Journal of Pediatric Surgery 22, no. 6 (June 1987): 497–500. http://dx.doi.org/10.1016/s0022-3468(87)80204-x.
Повний текст джерелаChou, Alexander J., Eugenie S. Kleinerman, Mark D. Krailo, Zhengjia Chen, Donna L. Betcher, John H. Healey, Ernest U. Conrad, et al. "Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma." Cancer 115, no. 22 (July 27, 2009): 5339–48. http://dx.doi.org/10.1002/cncr.24566.
Повний текст джерелаMori, Kanji, Kosei Ando, and Dominique Heymann. "Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases." Expert Review of Anticancer Therapy 8, no. 2 (February 2008): 151–59. http://dx.doi.org/10.1586/14737140.8.2.151.
Повний текст джерелаGalligionl, E., M. Quaia, A. Freschi, A. Spada, D. Favaro, M. Sanarosa, C. Sacco, and D. Alberti. "Biological and clinical activity of liposomes containing muramyl tripeptide LMTP-PE on melanoma patients." Melanoma Research 3, no. 1 (March 1993): 76. http://dx.doi.org/10.1097/00008390-199303000-00282.
Повний текст джерелаDing, Jin Wen, Roland Andersson, Vasile L. Soltesz, Håkan Pärsson, Kjell Johansson, Wenqi Wang, and Stig Bengmark. "Inhibition of bacterial translocation in obstructive jaundice by muramyl tripeptide phosphatidylethanolamine in the rat." Journal of Hepatology 20, no. 6 (January 1994): 720–28. http://dx.doi.org/10.1016/s0168-8278(05)80141-2.
Повний текст джерелаCalvo-Mateo, Ana, María-José Camarasa, and Federico G. De las Heras. "N-(glucopyranosid-3-yl)--alanyl--alanyl--isoglutamine and related tripeptide analogues of muramyl dipeptide." Tetrahedron 42, no. 14 (January 1986): 4049–56. http://dx.doi.org/10.1016/s0040-4020(01)87561-x.
Повний текст джерелаMaeda, Miho, Takeshi Asano, and Eugenie S. Kleinerman. "Anti-(tumor necrosis factor) alters the response of human monocytes to liposomal muramyl tripeptide." Cancer Immunology Immunotherapy 37, no. 3 (May 1993): 203–8. http://dx.doi.org/10.1007/bf01525436.
Повний текст джерелаTaçyıldız, Nurdan, Emel Unal, Handan Dinçaslan, H. Mine Çakmak, Kenan Köse, Gülşah Tanyıldız, and Ömer Kartal. "Muramyl Tripeptide Plus Chemotherapy Reduces Metastasis in Non-Metastatic Osteosarcoma: A Single-Center Experience." Asian Pacific Journal of Cancer Prevention 21, no. 3 (March 1, 2020): 715–20. http://dx.doi.org/10.31557/apjcp.2020.21.3.715.
Повний текст джерелаIzbicki, J. R., C. Raedler, A. Anke, P. Brunner, M. Siebeck, E. Leinisch, R. Lüttiken, G. Ruckdeschel, D. K. Wilker, and L. Schweiberer. "Beneficial effect of liposome-encapsulated muramyl tripeptide in experimental septicemia in a porcine model." Infection and Immunity 59, no. 1 (1991): 126–30. http://dx.doi.org/10.1128/iai.59.1.126-130.1991.
Повний текст джерелаShaw, J. M., W. S. Futch, and L. B. Schook. "Induction of macrophage antitumor activity by acetylated low density lipoprotein containing lipophilic muramyl tripeptide." Proceedings of the National Academy of Sciences 85, no. 16 (August 1, 1988): 6112–16. http://dx.doi.org/10.1073/pnas.85.16.6112.
Повний текст джерелаMelissen, P. M., W. van Vianen, Y. Rijsbergen, and I. A. Bakker-Woudenberg. "Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide in treatment of experimental Klebsiella pneumoniae infection." Infection and Immunity 60, no. 1 (1992): 95–101. http://dx.doi.org/10.1128/iai.60.1.95-101.1992.
Повний текст джерелаFavaro, D., M. Santarosa, M. Quaia, A. Spada, A. Freschi, R. Talmini, and E. Galligioni. "Soluble intercellular adhesion molecule-1 in melanoma patients treated with liposomes containing muramyl tripeptide." European Journal of Cancer 31, no. 6 (June 1995): 1026–27. http://dx.doi.org/10.1016/0959-8049(95)00118-2.
Повний текст джерелаGay, Brigitte, Jean-Michel Cardot, Christian Schnell, Peter Van Hoogevest, and Daniel Gygax. "Comparative Pharmacokinetics of Free Muramyl Tripeptide Phosphatidyl Ethanolamine (MTP-PE) and Liposomal MTP-PE." Journal of Pharmaceutical Sciences 82, no. 10 (October 1993): 997–1001. http://dx.doi.org/10.1002/jps.2600821005.
Повний текст джерелаDalmasso, Guillaume, Hang Thi Thu Nguyen, Laetitia Charrier-Hisamuddin, Yutao Yan, Hamed Laroui, Benjamin Demoulin, Shanthi V. Sitaraman та Didier Merlin. "PepT1 mediates transport of the proinflammatory bacterial tripeptide l-Ala-γ-d-Glu-meso-DAP in intestinal epithelial cells". American Journal of Physiology-Gastrointestinal and Liver Physiology 299, № 3 (вересень 2010): G687—G696. http://dx.doi.org/10.1152/ajpgi.00527.2009.
Повний текст джерелаMacEwen, E. Gregory, Fushun Shi, and Ilene D. Kurzman. "IN VIVO EFFECT OF CHEMOTHERAPY COMBINED WITH LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE ON CANINE MONOCYTE ACTIVATION." Journal of Immunotherapy 13, no. 1 (January 1993): 65. http://dx.doi.org/10.1097/00002371-199301000-00036.
Повний текст джерелаKoff, W., S. Showalter, B. Hampar, and I. Fidler. "Protection of mice against fatal herpes simplex type 2 infection by liposomes containing muramyl tripeptide." Science 228, no. 4698 (April 26, 1985): 495–97. http://dx.doi.org/10.1126/science.2984772.
Повний текст джерелаVerweij, J., I. Judson, W. Steward, C. A. van Oosterom. van Pottelsberghe, M. van Glabbeke, and H. Mouridsen. "Phase II study with liposomal muramyl tripeptide phophatidylethanolamine (MTP/PE) in soft tissue sarcomas (STS)." European Journal of Cancer 29 (January 1993): S184. http://dx.doi.org/10.1016/0959-8049(93)91647-4.
Повний текст джерелаBarr, P. J., K. M. Green, H. L. Gibson, I. C. Bathurst, I. A. Quakyi, and D. C. Kaslow. "Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals." Journal of Experimental Medicine 174, no. 5 (November 1, 1991): 1203–8. http://dx.doi.org/10.1084/jem.174.5.1203.
Повний текст джерелаTanaka, Motoharu, and Shigeru Abe. "Combination therapy of liposome-entrapped muramyl tripeptide phosphatidylethanolamine (L-MTP-PE) against syngeneic tumors in mice." Proceedings for Annual Meeting of The Japanese Pharmacological Society 93 (2020): 3—P—344. http://dx.doi.org/10.1254/jpssuppl.93.0_3-p-344.
Повний текст джерелаMelissen, P. M., W. van Vianen, and I. A. Bakker-Woudenberg. "Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide." Antimicrobial Agents and Chemotherapy 38, no. 1 (January 1, 1994): 147–50. http://dx.doi.org/10.1128/aac.38.1.147.
Повний текст джерелаKleinerman, E. S., J. S. Snyder, and N. Jaffe. "Influence of chemotherapy administration on monocyte activation by liposomal muramyl tripeptide phosphatidylethanolamine in children with osteosarcoma." Journal of Clinical Oncology 9, no. 2 (February 1991): 259–67. http://dx.doi.org/10.1200/jco.1991.9.2.259.
Повний текст джерелаFavaro, Daniela, Manuela Santarosa, Michele Quaia, Antonella Spada, Andrea Freschi, Renato Talamini, and Enzo Galligioni. "Soluble Intercellular Adhesion Molecule-1 and Serum Cytokines in Melanoma Patients Treated with Liposomes Containing Muramyl Tripeptide." Tumori Journal 81, no. 3 (May 1995): 185–90. http://dx.doi.org/10.1177/030089169508100306.
Повний текст джерелаKurzman, Ilene D., Haiyan Cheng, and E. Gregory MacEwen. "Effect of Liposome-Muramyl Tripeptide Combined with Recombinant Canine Granulocyte Colony-Stimulating Factor on Canine Monocyte Activity." Cancer Biotherapy 9, no. 2 (January 1994): 113–22. http://dx.doi.org/10.1089/cbr.1994.9.113.
Повний текст джерелаKleinerman, E. S., S. F. Jia, J. Griffin, N. L. Seibel, R. S. Benjamin, and N. Jaffe. "Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration." Journal of Clinical Oncology 10, no. 8 (August 1992): 1310–16. http://dx.doi.org/10.1200/jco.1992.10.8.1310.
Повний текст джерелаMiwa, Shinji, Toshiharu Shirai, Norio Yamamoto, Katsuhiro Hayashi, Akihiko Takeuchi, Kentaro Igarashi, and Hiroyuki Tsuchiya. "Current and Emerging Targets in Immunotherapy for Osteosarcoma." Journal of Oncology 2019 (January 1, 2019): 1–8. http://dx.doi.org/10.1155/2019/7035045.
Повний текст джерелаMahapatra, Sebabrata, Hataichanok Scherman, Patrick J. Brennan, and Dean C. Crick. "N Glycolylation of the Nucleotide Precursors of Peptidoglycan Biosynthesis of Mycobacterium spp. Is Altered by Drug Treatment." Journal of Bacteriology 187, no. 7 (April 1, 2005): 2341–47. http://dx.doi.org/10.1128/jb.187.7.2341-2347.2005.
Повний текст джерелаMacewen, E. G., I. D. Kurzman, S. Helfand, D. Vail, C. London, W. Kisseberth, R. C. Rosenthal, et al. "Current Studies of Liposome Muramyl Tripeptide (CGP 19835A Lipid) Therapy for Metastasis in Spontaneous Tumors: A Progress Review*." Journal of Drug Targeting 2, no. 5 (January 1994): 391–96. http://dx.doi.org/10.3109/10611869408996814.
Повний текст джерелаMaeda, Miho, Rebecca D. Knowles, and Eugenie S. Kleinerman. "Muramyl Tripeptide Phosphatidylethanolamine Encapsulated in Liposomes Stimulates Monocyte Production of Tumor Necrosis Factor and Interleukin-1 In Vitro." Cancer Communications 3, no. 10 (January 1, 1991): 313–21. http://dx.doi.org/10.3727/095535491820873740.
Повний текст джерелаMeyers, Paul A., Cindy L. Schwartz, Mark D. Krailo, John H. Healey, Mark L. Bernstein, Donna Betcher, William S. Ferguson, et al. "Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group." Journal of Clinical Oncology 26, no. 4 (February 1, 2008): 633–38. http://dx.doi.org/10.1200/jco.2008.14.0095.
Повний текст джерелаGangemi, J. D., M. Nachtigal, D. Barnhart, L. Krech, and P. Jani. "Therapeutic Efficacy of Liposome-Encapsulated Ribavirin and Muramyl Tripeptide in Experimental Infection with Influenza or Herpes Simplex Virus." Journal of Infectious Diseases 155, no. 3 (March 1, 1987): 510–17. http://dx.doi.org/10.1093/infdis/155.3.510.
Повний текст джерелаGuan, Rongjin, Abhijit Roychowdury, Brian Ember, Sanjay Kumar, Geert-Jan Boons, and Roy A. Mariuzza. "Crystal structure of a peptidoglycan recognition protein (PGRP) in complex with a muramyl tripeptide from Gram-positive bacteria." Journal of Endotoxin Research 11, no. 1 (February 1, 2005): 41–46. http://dx.doi.org/10.1179/096805105225006713.
Повний текст джерелаGuan, Rongjin, Abhijit Roychowdury, Brian Ember, Sanjay Kumar, Geert-Jan Boons, and Roy A. Mariuzza. "Crystal structure of a peptidoglycan recognition protein (PGRP) in complex with a muramyl tripeptide from Gram-positive bacteria." Journal of Endotoxin Research 11, no. 1 (February 2005): 41–46. http://dx.doi.org/10.1177/09680519050110010901.
Повний текст джерелаFujimaki, Wakae, Kyogo Itoh, Taeha An, Jacalyn B. Gano, Merrick I. Ross, Paul F. Mansfield, Charles M. Balch, et al. "Cytokine Production and Immune Cell Activation in Melanoma Patients Treated with Liposomal Muramyl Tripeptide (CGP 19835A Lipid)1." Cancer Biotherapy 8, no. 4 (January 1993): 307–18. http://dx.doi.org/10.1089/cbr.1993.8.307.
Повний текст джерела